0001567619-18-004139.txt : 20181015 0001567619-18-004139.hdr.sgml : 20181015 20181015161319 ACCESSION NUMBER: 0001567619-18-004139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181011 FILED AS OF DATE: 20181015 DATE AS OF CHANGE: 20181015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Samuel M. CENTRAL INDEX KEY: 0001618037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 181122354 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2018-10-11 0 0000722723 HANGER, INC. HNGR 0001618037 Liang Samuel M. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Executive Vice President* Common Stock 2018-10-11 4 F 0 305 19.40 D 138271 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 72231 72231 D Performance Share Units 2020-05-19 Common Stock 28892 28892 D Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Includes (i) unvested restricted shares and fully vested shares totaling 22,186 shares of stock from an initial grant of 23,625 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; (ii) unvested restricted shares totaling 20,701 shares of stock from an initial grant of 20,701 shares of restricted stock that begins to vest on March 9, 2019; (iii) unvested restricted shares and fully vested shares totaling 20,666 shares of stock from an initial grant of 20,666 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 7, 2018 and 2019; (iv) unvested restricted shares and fully vested shares totaling 21,130 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 8, 2018; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 4,695 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (vi) unvested restricted shares and fully vested shares totaling 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 7, 2017; (vii) unvested restricted shares and fully vested shares totaling 13,777 shares of stock from an initial grant of 13,777 shares of restricted stock made on March 6, 2015 and (viii) fully vested shares totaling 12,616 shares of stock from an initial grant of 14,745 shares of restricted stock made on May 19, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. * The reporting person is Executive Vice President of Hanger, Inc. and President and Chief Operating Officer of Hanger Prosthetics & Orthotics, Inc. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Samuel M. Liang 2018-10-15